《盈利預喜》中國核能科技(00611.HK)料至6月底純利增長最少15%
中國核能科技(00611.HK)公布,與截至去年同期之純利相比,預期集團於截至今年6月30日止期間之業績錄得之純利將增加不少於15%,主要源於與去年相比,集團之工程、採購及建設(EPC)以及諮詢及整體建設分部預期於期間將錄得純利減少,主要由於預期減值撥備的影響及市場競爭加劇;集團的發電分部(主要是期內營運之睢寧縣風電站的貢獻)預期將為集團帶來正面影響,集團自主持有的風電站預期會產生穩定收益及溢利。與去年相比,集團之相關業務於期間預期錄得純利增加;及與去年相比,集團融資分部於期間預期錄得淨虧損減少,該業務分部期內專注於集團內之融資租賃項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.